Diethylamine

Diethylamine

SCHEMBL6716353

CCCCC(Cc1ccc(OCCNC(=O)c2ccccc2)cc1)C(=O)OCC.CCNCC

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.53
RAB9A P51151 5/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
PPARG P37231 4/20 0.51
PPARA Q07869 2/20 0.51
EPHX2 P34913 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
HPGD P15428 1/20 0.50
PTGES O14684 1/20 0.48
ALOX5 P09917 1/20 0.48
MAPT P10636 2/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
POLB P06746 1/20 0.47
CASP3 P42574 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
LTA4H P09960 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL6805517 0.91 NPC1 (0.55) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6716388 0.91 NPC1 (0.55) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6712853 0.86 PPARG (0.51) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6718906 0.85 NR1H4 (0.48) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6716299 0.85 EPHX2 (0.58) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6713633 0.85 EPHX2 (0.48) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6715969 0.85 NPC1 (0.48) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6716127 0.84 NPC1 (0.46) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6716102 0.84 EPHX2 (0.50) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6716351 0.84 EPHX2 (0.48) NPC1RAB9AMEN1KMT2APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 NPC1 812/4885RAB9A 3140/4885MEN1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.